Curis CRIS
NASDAQ CRIS
$0.83 0.00 (-0.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Curis (CRIS) Research & Development (2010 - 2026)

Updated

Curis (CRIS) posted Research & Development of $6.71 million for Q2 2026, down 10.0% from $7.46 million a year earlier but up 4.1% from the prior quarter.

Analysis

Curis (CRIS) Research & Development (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Curis was $25.42 million, down 26.7% year-over-year; for FY2025, it was $28.25 million, down 26.7% from FY2024.

  • Annual Research & Development has declined for three consecutive years, though with a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
  • In prior years, Curis' Research & Development was $38.56 million in FY2024 (-2.4%), $39.5 million in FY2023 (-8.7%), $43.28 million in FY2022 (+24.1%) and $34.88 million in FY2021 (+51.2%).
  • Quarterly Research & Development has run from a low of $5.83 million in Q4 2025 to a high of $12.32 million in Q2 2022 over five years.
  • On a year-over-year basis, Research & Development has declined in each of the last eight quarters, with an average decline of 19.8% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 92.0%; the weakest was Q4 2025, with a decline of 35.0%.
  • According to Business Quant data, Research & Development for the three prior quarters was $6.45 million (Q1 2026), $5.83 million (Q4 2025) and $6.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Curis 1.62 Mn -32.57 Mn - 6.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.71 Mn
Mar 31, 2026 6.45 Mn
Dec 31, 2025 5.83 Mn
Sep 30, 2025 6.43 Mn
Jun 30, 2025 7.46 Mn
Mar 31, 2025 8.54 Mn
Dec 31, 2024 8.97 Mn
Sep 30, 2024 9.72 Mn
Jun 30, 2024 10.25 Mn
Mar 31, 2024 9.62 Mn
Dec 31, 2023 9.96 Mn
Sep 30, 2023 10.38 Mn
Jun 30, 2023 10.01 Mn
Mar 31, 2023 9.14 Mn
Dec 31, 2022 8.71 Mn
Sep 30, 2022 10.81 Mn
Jun 30, 2022 12.32 Mn
Mar 31, 2022 11.44 Mn
Dec 31, 2021 10.77 Mn
Sep 30, 2021 8.60 Mn
API Access

Curis Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CRIS&period=max&api_key=YOUR_API_KEY